JP2010527347A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010527347A5 JP2010527347A5 JP2010508001A JP2010508001A JP2010527347A5 JP 2010527347 A5 JP2010527347 A5 JP 2010527347A5 JP 2010508001 A JP2010508001 A JP 2010508001A JP 2010508001 A JP2010508001 A JP 2010508001A JP 2010527347 A5 JP2010527347 A5 JP 2010527347A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- controlled release
- release dosage
- active agent
- pharmaceutically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002552 dosage form Substances 0.000 claims description 27
- 239000013543 active substance Substances 0.000 claims description 19
- 238000013270 controlled release Methods 0.000 claims description 12
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 8
- 150000002632 lipids Chemical class 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000007906 compression Methods 0.000 claims description 2
- 230000006835 compression Effects 0.000 claims description 2
- 235000015872 dietary supplement Nutrition 0.000 claims description 2
- 229940088679 drug related substance Drugs 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 229940049654 glyceryl behenate Drugs 0.000 claims description 2
- -1 magnesium metasilicate aluminate Chemical class 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0709541.7A GB0709541D0 (en) | 2007-05-17 | 2007-05-17 | Pharmaceutical excipient |
| PCT/IB2008/002128 WO2008142572A2 (en) | 2007-05-17 | 2008-05-16 | Controlled release tablet formulation containing magnesium aluminometasilicate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010527347A JP2010527347A (ja) | 2010-08-12 |
| JP2010527347A5 true JP2010527347A5 (enExample) | 2012-03-15 |
Family
ID=38234655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010508001A Pending JP2010527347A (ja) | 2007-05-17 | 2008-05-16 | メタケイ酸アルミン酸マグネシウム含有放出制御錠剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100196475A1 (enExample) |
| EP (1) | EP2152248A2 (enExample) |
| JP (1) | JP2010527347A (enExample) |
| CN (1) | CN101677962B (enExample) |
| AU (1) | AU2008252481B2 (enExample) |
| CA (1) | CA2684366A1 (enExample) |
| GB (1) | GB0709541D0 (enExample) |
| IL (1) | IL201901A0 (enExample) |
| WO (1) | WO2008142572A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2403482T3 (pl) | 2009-03-04 | 2018-06-29 | Emplicure Ab | Preparat odporny na nadużywanie |
| CA2761000C (en) | 2009-05-08 | 2018-05-29 | Orexo Ab | Composition for sustained drug delivery comprising geopolymeric binder |
| CN102762205B (zh) * | 2010-02-26 | 2014-03-12 | 东丽株式会社 | 包衣固体制剂 |
| WO2012032337A2 (en) | 2010-09-07 | 2012-03-15 | Orexo Ab | A transdermal drug administration device |
| CN104523627B (zh) * | 2014-12-18 | 2017-04-12 | 成都苑东生物制药股份有限公司 | 一种硫酸氢氯吡格雷片药物组合物及其制备方法 |
| US10166185B2 (en) | 2015-06-09 | 2019-01-01 | J. Rettenmaier & Söhne Gmbh + Co Kg | Excipient and oral solid dosage forms for oily drugs |
| WO2016201119A1 (en) * | 2015-06-09 | 2016-12-15 | J. Rettenmaier & Söhne Gmbh + Co Kg | Excipient and oral solid dosage forms for oily drugs |
| AU2017227070B2 (en) | 2016-02-29 | 2022-03-31 | Emplicure Ab | Devices for evaporation and inhalation of active agents |
| CN105769798A (zh) * | 2016-05-16 | 2016-07-20 | 张阳 | 一种高血压治疗药物的制备方法 |
| CN105997915A (zh) * | 2016-05-16 | 2016-10-12 | 张阳 | 一种高血压治疗用缓释片剂 |
| GB201714412D0 (en) | 2017-09-07 | 2017-10-25 | Emplicure Ab | Evaporation devices containing plant material |
| CN114146061B (zh) * | 2020-09-07 | 2023-06-30 | 歌礼生物科技（杭州）有限公司 | 包含固体分散体的蛋白酶抑制剂增效组合物及其制备方法 |
| CN114149011A (zh) * | 2020-09-08 | 2022-03-08 | 浙江丰虹新材料股份有限公司 | 一种药用辅料硅酸铝镁及其合成方法 |
| US20250228771A1 (en) * | 2022-04-01 | 2025-07-17 | EMPLICURE AB (publ) | Alkaline intraoral products |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53148519A (en) * | 1977-05-31 | 1978-12-25 | Sumitomo Chem Co Ltd | Preparation of solid medicine containing gefarnate |
| JPS58109411A (ja) * | 1981-12-23 | 1983-06-29 | Shionogi & Co Ltd | ニフエジピン固型製剤組成物 |
| BE1004461A5 (fr) * | 1991-01-30 | 1992-11-24 | Wellcome Found | Comprimes dispersables dans l'eau. |
| EP0893992B1 (en) * | 1996-04-16 | 2004-03-03 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
| JPH11286438A (ja) * | 1998-03-31 | 1999-10-19 | Shiseido Co Ltd | 徐放性製剤 |
| WO2000038655A1 (en) * | 1998-12-23 | 2000-07-06 | Alza Corporation | Dosage forms comprising porous particles |
| TW471968B (en) * | 1999-08-25 | 2002-01-11 | Committee On Chinese Medicine | Solamargine pharmaceutical composition for killing cancer cells |
| EP1285655B1 (en) * | 2000-04-11 | 2007-05-30 | Sankyo Company, Limited | Stabilized pharmaceutical compositions containing the calcium channel blocker azelnidipine |
| AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
| US20030203029A1 (en) * | 2001-12-14 | 2003-10-30 | Wong Patrick S.-L. | Controlled release liquid active agent formulation dosage forms |
| IL153277A0 (en) * | 2002-12-04 | 2003-07-06 | Pharmos Corp | High enantiomeric purity dexanabinol for pharmaceutical compositions |
| US20060177506A1 (en) * | 2003-03-17 | 2006-08-10 | Shigeo Yanai | Release control compositions |
| US20050181049A1 (en) * | 2003-11-19 | 2005-08-18 | Dong Liang C. | Composition and method for enhancing bioavailability |
| AU2004294674B2 (en) * | 2003-12-01 | 2009-02-26 | Recordati Ireland Limited | Pharmaceutical compositions comprising lercanidipine |
| JP3996626B2 (ja) * | 2004-06-22 | 2007-10-24 | 塩野義製薬株式会社 | 口腔内速崩壊錠 |
| CN1976751A (zh) * | 2004-06-28 | 2007-06-06 | H.隆德贝克有限公司 | 释放化学物质的多孔物品 |
| US20060057206A1 (en) * | 2004-08-19 | 2006-03-16 | Wong Patrick S | Controlled release nanoparticle active agent formulation dosage forms and methods |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| WO2006082523A2 (en) * | 2005-01-25 | 2006-08-10 | Aurobindo Pharma Limited | Pharmaceutical sustained release composition of metformin |
-
2007
- 2007-05-17 GB GBGB0709541.7A patent/GB0709541D0/en not_active Ceased
-
2008
- 2008-05-16 JP JP2010508001A patent/JP2010527347A/ja active Pending
- 2008-05-16 WO PCT/IB2008/002128 patent/WO2008142572A2/en not_active Ceased
- 2008-05-16 US US12/451,525 patent/US20100196475A1/en not_active Abandoned
- 2008-05-16 CN CN2008800156313A patent/CN101677962B/zh not_active Expired - Fee Related
- 2008-05-16 EP EP08789077A patent/EP2152248A2/en not_active Withdrawn
- 2008-05-16 CA CA002684366A patent/CA2684366A1/en not_active Abandoned
- 2008-05-16 AU AU2008252481A patent/AU2008252481B2/en not_active Expired - Fee Related
-
2009
- 2009-11-03 IL IL201901A patent/IL201901A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010527347A5 (enExample) | ||
| JP2009525985A5 (enExample) | ||
| JP2015523407A5 (enExample) | ||
| NZ590291A (en) | Pharmaceutical compositions for treatment of parkinson's disease | |
| JP2013501717A5 (enExample) | ||
| JP2009525343A5 (enExample) | ||
| JP2010509367A5 (enExample) | ||
| JP2008501025A5 (enExample) | ||
| NZ610701A (en) | Once daily formulation of lacosamide | |
| AR075735A1 (es) | Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso | |
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2011512349A5 (enExample) | ||
| JP2013516493A5 (enExample) | ||
| MX2015011896A (es) | Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia. | |
| MX2020011961A (es) | Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas. | |
| JP2013231087A5 (enExample) | ||
| HRP20170734T1 (hr) | Povećana biodostupnost lijeka u terapiji naltreksonom | |
| WO2009034431A3 (en) | Controlled-release dosage forms for varenicline | |
| TN2011000307A1 (en) | Galenic formulation of organic compounds | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| JP2013544290A5 (enExample) | ||
| JP2015508082A5 (enExample) | ||
| WO2012053785A3 (ko) | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 | |
| WO2011159100A2 (ko) | 항암 활성을 나타내는 약제학적 조성물 | |
| PH12014502609B1 (en) | Multilayer coating form of orally administered pharmaceutical composition containing omega-3 fatty acid or alkyl ester thereof and statin based drug |